UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies

Structure (London), 2016-08, Vol.24 (8), p.1346-1357

2016

Volltextzugriff (PDF)

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

Virology (New York, N.Y.), 2018-01, Vol.514, p.106-117

2018

Volltextzugriff (PDF)

Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes

Journal of virological methods, 2015-12, Vol.226, p.15-24

2015

Volltextzugriff (PDF)

Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity

Protein expression and purification, 2013-07, Vol.90 (1), p.34-39

2013

Volltextzugriff (PDF)

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

Vaccine, 2014-11, Vol.32 (48), p.6527-6536

2014

Volltextzugriff (PDF)

DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice

Vaccine, 2006-03, Vol.24 (13), p.2324-2332

2006

Volltextzugriff (PDF)

Corrigendum to “DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice” [Vaccine 24 (2006) 2324–2332]

Vaccine, 2006-06, Vol.24 (23), p.5092-5092

2006

Volltextzugriff (PDF)

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection

Vaccine, 2004-06, Vol.22 (17), p.2261-2272

2004

Volltextzugriff (PDF)

Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing

Virology (New York, N.Y.), 2004-06, Vol.323 (2), p.208-219

2004

Volltextzugriff (PDF)

Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus

Virology (New York, N.Y.), 1990-11, Vol.179 (1), p.321-329

1990

Volltextzugriff (PDF)

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

Immunology letters, 1996-06, Vol.51 (1), p.107-114

1996

Volltextzugriff (PDF)

Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4 + cells

Virology (New York, N.Y.), 1992, Vol.186 (1), p.313-317

1992

Volltextzugriff (PDF)

HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles

Virology (New York, N.Y.), 1991-08, Vol.183 (2), p.487-495

1991

Volltextzugriff (PDF)

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6

Virology (New York, N.Y.), 2003-03, Vol.308 (1), p.178-190

2003

Volltextzugriff (PDF)

Protection from pathogenic SIV challenge using multigenic DNA vaccines

Immunology letters, 1999-03, Vol.66 (1), p.183-188

1999

Volltextzugriff (PDF)

Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies

Structure (London), 2016-08, Vol.24 (8)

2016

Volltextzugriff (PDF)

Synthesis of an active hybrid growth factor (GF) in bacteria: transforming GF-α/vaccinia GF fusion protein

Gene, 1987, Vol.60 (2), p.175-182

1987

Volltextzugriff (PDF)

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

Immunology letters, 1996-06, Vol.51 (1), p.115-119

1996

Volltextzugriff (PDF)

Conservation of DNA Sequence in the Predicted Major Late Promoter Regions of Selected Mastadenoviruses

Virology (New York, N.Y.), 1996-06, Vol.220 (2), p.390-401

1996

Volltextzugriff (PDF)

Tumorigenic poxviruses: Characterization of the expression of an epidermal growth factor related gene in shope fibroma virus

Virology (New York, N.Y.), 1990-12, Vol.179 (2), p.926-930

1990

Volltextzugriff (PDF)

Translational control of SV40 T antigen expressed from the adenovirus late promoter

Cell, 1983-06, Vol.33 (2), p.455-464

1983

Volltextzugriff (PDF)

Regulation of integration by coliphage λ: Activation of int transcription by the cII and cIII proteins

Virology (New York, N.Y.), 1979-01, Vol.92 (2), p.542-556

1979

Volltextzugriff (PDF)

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6)

Virology (New York, N.Y.), 2003-03, Vol.308 (1), p.178-190

2003

Volltextzugriff (PDF)

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV 89.6

Virology (New York, N.Y.), 2003, Vol.308 (1), p.178-190

2003

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

ScienceDirect Journals (5 years ago - present)
(29)
IngentaConnect
(28)
MEDLINE
(21)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(18)
IngentaConnect Journals
(4)

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes

Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity

Prime–boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: Efficacy against repeated mucosal R5 clade C SHIV challenges

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice

Corrigendum to “DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice” [Vaccine 24 (2006) 2324–2332]

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection

Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing

Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4 + cells

HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6

Protection from pathogenic SIV challenge using multigenic DNA vaccines

Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies

Synthesis of an active hybrid growth factor (GF) in bacteria: transforming GF-α/vaccinia GF fusion protein

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

Conservation of DNA Sequence in the Predicted Major Late Promoter Regions of Selected Mastadenoviruses

Tumorigenic poxviruses: Characterization of the expression of an epidermal growth factor related gene in shope fibroma virus

Translational control of SV40 T antigen expressed from the adenovirus late promoter

Regulation of integration by coliphage λ: Activation of int transcription by the cII and cIII proteins

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6)

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV 89.6

Aktive Filter

Suchergebnisse filtern